Health Canada under fire for pulling Adderall XR
The FDA is criticized for pulling Vioxx too late, Health Canada for pulling Adderall XR too early. You can never win.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Polycystic ovary syndrome is more than ovarian
-
Metrics got you into medicine and are making you unhappy in it [PODCAST]
-
3 fixes for primary care access in the ChatGPT era
-
Why does post-discharge care keep breaking down?
-
The residency personal statement is an identity problem
-
Is coaching in medical education replacing mentorship?
-
Past 6 Months
-
I Googled my own name and a corporate clinic I’ve never worked at appeared [PODCAST]
-
Primary care crisis requires new training and skills
-
Polycystic ovary syndrome is more than ovarian
-
Why nursing home regulations must address mental illness
-
Your doctor saved your life but won’t return your call [PODCAST]
-
How corporate medicine is eroding truth and patient dignity
-
Recent Posts
-
I built clinical decision-support tools at the bedside
-
GLP-1s and neurotech are colliding over chronic pain
-
Physician contract review is about what is missing
-
Violence against doctors: 5 forces that ignite it
-
Why protein timing after bariatric surgery matters
-
Medication adherence is a communication problem
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
